VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders of Varian Medical Systems, Inc. (the “Company”) was held on February 14, 2019 (the “Stockholders’ Meeting”). The Company’s stockholders voted on the following three proposals at the Stockholders’ Meeting and cast their votes as set forth in the following tables. Each of these proposals is described in detail in the Company’s Proxy Statement.
Proposal One:
Elect the following individuals as directors for one-year terms ending with the 2020 Annual Meeting of Stockholders:
| For | Against | Abstain | Broker Non-Votes | |
| Anat Ashkenazi | 72,524,028 | 167,930 | 94,110 | 7,469,761 |
| Jeffrey R. Balser | 72,273,997 | 418,488 | 93,583 | 7,469,761 |
| Judy Bruner | 72,195,273 | 504,377 | 86,418 | 7,469,761 |
| Jean-Luc Butel | 72,330,693 | 364,726 | 90,649 | 7,469,761 |
| Regina E. Dugan | 71,982,526 | 717,338 | 86,204 | 7,469,761 |
| R. Andrew Eckert | 71,443,901 | 1,260,951 | 81,216 | 7,469,761 |
| Timothy E. Guertin | 72,188,825 | 516,305 | 80,938 | 7,469,761 |
| David J. Illingworth | 71,849,470 | 847,954 | 88,644 | 7,469,761 |
| Dow R. Wilson | 72,331,506 | 371,129 | 83,433 | 7,469,761 |
Proposal Two:
Approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers:
| For | Against | Abstain | Broker Non-Votes |
| 68,056,711 | 4,563,376 | 165,981 | 7,469,761 |
Proposal Three:
Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2019:
| For | Against | Abstain | Broker Non-Votes (1) |
| 77,376,298 | 2,750,766 | 128,765 | — |
(1) to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners.
(S)
About VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR)
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions. The Company is an also a supplier of X-ray imaging components. It operates through two segments: Oncology Systems and Imaging Components. The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy and treatments, and brachytherapy, as well as informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for cancer clinics, radiotherapy centers and medical oncology practices. The Imaging Components segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer-aided diagnostics and industrial applications.
